Compile Data Set for Download or QSAR
Report error Found 76 Enz. Inhib. hit(s) with all data for entry = 10532
TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546521(US11292782, Compound 2)
Affinity DataIC50: 31nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546550(US11292782, Compound 8)
Affinity DataIC50: 47.2nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546564(US11292782, Compound 9)
Affinity DataIC50: 49.1nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546701(US11292782, Compound 31)
Affinity DataIC50: 62nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546715(US11292782, Compound 65)
Affinity DataIC50: 64nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546692(US11292782, Compound 30)
Affinity DataIC50: 73nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546711(US11292782, Compound 42)
Affinity DataIC50: 77nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546719(US11292782, Compound 73)
Affinity DataIC50: 92nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546535(US11292782, Compound 5)
Affinity DataIC50: 93nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546663(US11292782, Compound 25)
Affinity DataIC50: 99nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546713(US11292782, Compound 45)
Affinity DataIC50: 99nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546570(US11292782, Compound 12)
Affinity DataIC50: 108nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546714(US11292782, Compound 60)
Affinity DataIC50: 115nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546716(US11292782, Compound 68)
Affinity DataIC50: 120nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546703(US11292782, Compound 32)
Affinity DataIC50: 120nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546565(US11292782, Compound 11)
Affinity DataIC50: 120nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546712(US11292782, Compound 44)
Affinity DataIC50: 120nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546543(US11292782, Compound 7)
Affinity DataIC50: 180nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546528(US11292782, Compound 3)
Affinity DataIC50: 180nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546661(US11292782, Compound 23)
Affinity DataIC50: 180nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546710(US11292782, Compound 39)
Affinity DataIC50: 200nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546709(US11292782, Compound 38)
Affinity DataIC50: 240nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546706(US11292782, Compound 33)
Affinity DataIC50: 304nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546598(US11292782, Compound 15)
Affinity DataIC50: 320nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546606(US11292782, Compound 18)
Affinity DataIC50: 358nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546717(US11292782, Compound 69)
Affinity DataIC50: 380nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546530(US11292782, Compound 4)
Affinity DataIC50: 386nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546607(US11292782, Compound 19)
Affinity DataIC50: 453nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546687(US11292782, Compound 27)
Affinity DataIC50: 496nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546707(US11292782, Compound 36)
Affinity DataIC50: 580nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546718(US11292782, Compound 71)
Affinity DataIC50: 589nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546539(US11292782, Compound 6)
Affinity DataIC50: 778nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546689(US11292782, Compound 29)
Affinity DataIC50: 910nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546517(US11292782, Compound 1)
Affinity DataIC50: 968nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546662(US11292782, Compound 24)
Affinity DataIC50: 1.09E+3nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546655(US11292782, Compound 20)
Affinity DataIC50: 1.87E+3nMAssay Description:Human AR cDNA cloned into pCMV vector, GRE-LUC, and CMV-renilla-LUC were used to transfect cells. HEK-293 cells (ATCC) were plated at 120,000 cells p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546719(US11292782, Compound 73)
Affinity DataIC50: 2.96E+3nMAssay Description:COS-7 cells (ATCC, Manassas, Va.) were plated in 24 well plates in DME+5% csFBS without phenol red at 70,000 cells/well. Once the cells attached to t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546720(US11292782, Compound 76)
Affinity DataIC50: 3.31E+3nMAssay Description:COS-7 cells (ATCC, Manassas, Va.) were plated in 24 well plates in DME+5% csFBS without phenol red at 70,000 cells/well. Once the cells attached to t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546711(US11292782, Compound 42)
Affinity DataIC50: 1.00E+4nMAssay Description:COS-7 cells (ATCC, Manassas, Va.) were plated in 24 well plates in DME+5% csFBS without phenol red at 70,000 cells/well. Once the cells attached to t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546663(US11292782, Compound 25)
Affinity DataIC50: 1.00E+4nMAssay Description:COS-7 cells (ATCC, Manassas, Va.) were plated in 24 well plates in DME+5% csFBS without phenol red at 70,000 cells/well. Once the cells attached to t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546687(US11292782, Compound 27)
Affinity DataIC50: 1.00E+4nMAssay Description:COS-7 cells (ATCC, Manassas, Va.) were plated in 24 well plates in DME+5% csFBS without phenol red at 70,000 cells/well. Once the cells attached to t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546689(US11292782, Compound 29)
Affinity DataIC50: 1.00E+4nMAssay Description:COS-7 cells (ATCC, Manassas, Va.) were plated in 24 well plates in DME+5% csFBS without phenol red at 70,000 cells/well. Once the cells attached to t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546692(US11292782, Compound 30)
Affinity DataIC50: 1.00E+4nMAssay Description:COS-7 cells (ATCC, Manassas, Va.) were plated in 24 well plates in DME+5% csFBS without phenol red at 70,000 cells/well. Once the cells attached to t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546701(US11292782, Compound 31)
Affinity DataIC50: 1.00E+4nMAssay Description:COS-7 cells (ATCC, Manassas, Va.) were plated in 24 well plates in DME+5% csFBS without phenol red at 70,000 cells/well. Once the cells attached to t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546703(US11292782, Compound 32)
Affinity DataIC50: 1.00E+4nMAssay Description:COS-7 cells (ATCC, Manassas, Va.) were plated in 24 well plates in DME+5% csFBS without phenol red at 70,000 cells/well. Once the cells attached to t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546707(US11292782, Compound 36)
Affinity DataIC50: 1.00E+4nMAssay Description:COS-7 cells (ATCC, Manassas, Va.) were plated in 24 well plates in DME+5% csFBS without phenol red at 70,000 cells/well. Once the cells attached to t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546709(US11292782, Compound 38)
Affinity DataIC50: 1.00E+4nMAssay Description:COS-7 cells (ATCC, Manassas, Va.) were plated in 24 well plates in DME+5% csFBS without phenol red at 70,000 cells/well. Once the cells attached to t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546710(US11292782, Compound 39)
Affinity DataIC50: 1.00E+4nMAssay Description:COS-7 cells (ATCC, Manassas, Va.) were plated in 24 well plates in DME+5% csFBS without phenol red at 70,000 cells/well. Once the cells attached to t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546662(US11292782, Compound 24)
Affinity DataIC50: 1.00E+4nMAssay Description:COS-7 cells (ATCC, Manassas, Va.) were plated in 24 well plates in DME+5% csFBS without phenol red at 70,000 cells/well. Once the cells attached to t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM546712(US11292782, Compound 44)
Affinity DataIC50: 1.00E+4nMAssay Description:COS-7 cells (ATCC, Manassas, Va.) were plated in 24 well plates in DME+5% csFBS without phenol red at 70,000 cells/well. Once the cells attached to t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
Go to US Patent

Displayed 1 to 50 (of 76 total ) | Next | Last >>
Jump to: